Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Chouin

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2014
A compartmental model of mouse thrombopoiesis and erythropoiesis to predict bone marrow toxicity after internal irradiationNicolas Sas, Julie Rousseau, Frédérique Nguyen, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 13, 2012
Comparison of 211At-PRIT and 211At-RIT of ovarian microtumors in a nude mouse modelSofia H L Frost, Tom Bäck, Nicolas Chouin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2013
Ex vivo activity quantification in micrometastases at the cellular scale using the α-camera techniqueNicolas Chouin, Sture Lindegren, Sofia H L Frost, et al.
EJNMMI Research|June 14, 2023
From bench to bedside: <sup>64</sup>Cu/<sup>177</sup>Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applicationsSilvano Gnesin, Nicolas Chouin, Michel Cherel, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 3, 2019
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular CarcinomaStephan Walrand, Carlo Chiesa, Pablo Minguez Gabina, et al.
Nuclear Medicine and Biology|March 26, 2013
Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membraneSalomé Paillas, Vincent Boudousq, Bérengère Piron, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2022
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligandsKatarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, et al.
Cancers|April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft ModelMarisa Capitao, Justine Perrin, Sylvain Simon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2021
Targeted Alpha Particle Therapy Remodels the Tumor Microenvironment and Improves Efficacy of ImmunotherapyJustine Perrin, Marisa Capitao, Mathilde Allard, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2014
A compartmental model of mouse thrombopoiesis and erythropoiesis to predict bone marrow toxicity after internal irradiationNicolas Sas, Julie Rousseau, Frédérique Nguyen, et al.
Cancer Biotherapy & Radiopharmaceuticals|December 13, 2012
Comparison of 211At-PRIT and 211At-RIT of ovarian microtumors in a nude mouse modelSofia H L Frost, Tom Bäck, Nicolas Chouin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 14, 2013
Ex vivo activity quantification in micrometastases at the cellular scale using the α-camera techniqueNicolas Chouin, Sture Lindegren, Sofia H L Frost, et al.
EJNMMI Research|June 14, 2023
From bench to bedside: <sup>64</sup>Cu/<sup>177</sup>Lu 1C1m-Fc anti TEM-1: mice-to-human dosimetry extrapolations for future theranostic applicationsSilvano Gnesin, Nicolas Chouin, Michel Cherel, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 3, 2019
Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular CarcinomaStephan Walrand, Carlo Chiesa, Pablo Minguez Gabina, et al.
Nuclear Medicine and Biology|March 26, 2013
Apoptosis and p53 are not involved in the anti-tumor efficacy of ¹²⁵I-labeled monoclonal antibodies targeting the cell membraneSalomé Paillas, Vincent Boudousq, Bérengère Piron, et al.
Radiation Research|August 1, 2008
Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electronsJean-Pierre Pouget, Lore Santoro, Laure Raymond, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 14, 2022
EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligandsKatarina Sjögreen Gleisner, Nicolas Chouin, Pablo Minguez Gabina, et al.
Cancers|April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft ModelMarisa Capitao, Justine Perrin, Sylvain Simon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2021
Targeted Alpha Particle Therapy Remodels the Tumor Microenvironment and Improves Efficacy of ImmunotherapyJustine Perrin, Marisa Capitao, Mathilde Allard, et al.
Pageof 4